Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prophase Labs Inc (PRPH)

Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,526
  • Shares Outstanding, K 19,079
  • Annual Sales, $ 44,380 K
  • Annual Income, $ -16,780 K
  • 60-Month Beta -0.10
  • Price/Sales 1.38
  • Price/Cash Flow N/A
  • Price/Book 1.29
Trade PRPH with:

Options Overview Details

View History
  • Implied Volatility 163.39% ( +43.06%)
  • Historical Volatility 48.51%
  • IV Percentile 94%
  • IV Rank 73.07%
  • IV High 217.50% on 06/05/24
  • IV Low 16.52% on 08/11/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 18
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 674
  • Open Int (30-Day) 1,083

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.06 +1.63%
on 07/22/24
4.49 -30.78%
on 06/24/24
-1.28 (-29.16%)
since 06/21/24
3-Month
3.06 +1.63%
on 07/22/24
5.62 -44.66%
on 05/06/24
-1.79 (-36.53%)
since 04/22/24
52-Week
3.06 +1.63%
on 07/22/24
7.55 -58.81%
on 08/03/23
-3.93 (-55.82%)
since 07/21/23

Most Recent Stories

More News
ProPhase Dips on Moving Karkus up Ladder

ProPhase Labs, Inc. (NASDAQ: PRPH) fell Tuesday, as the company, a next generation biotech, genomics, ...

PRPH : 3.11 (-0.32%)
COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee

/PRNewswire/ -- COMSovereign Holding Corp. (NASDAQ: COMS and COMSP) ("COMSovereign" or the "Company"), a U.S.-based developer of 4G LTE Advanced and 5G...

COMS : 0.0300 (-57.14%)
PRPH : 3.11 (-0.32%)
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time

GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...

PRPH : 3.11 (-0.32%)
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced...

PRPH : 3.11 (-0.32%)
DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs

ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and...

DSS : 1.5700 (-0.63%)
PRPH : 3.11 (-0.32%)
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds

Confirms Quarterly Growth continues year-over-year Announces significant progress being made in Genomics Business Company to Host Live Webcast to...

PRPH : 3.11 (-0.32%)
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds Equivir and Equivir G ...

PRPH : 3.11 (-0.32%)
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its...

DSS : 1.5700 (-0.63%)
PRPH : 3.11 (-0.32%)
ProPhase Labs Announces Significant Laboratory Expansion

Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE...

PRPH : 3.11 (-0.32%)
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference

May 23-26, 2022 (HYBRID CONFERENCE) Garden City, NY, May 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and...

PRPH : 3.11 (-0.32%)

Business Summary

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals...

See More

Key Turning Points

3rd Resistance Point 3.44
2nd Resistance Point 3.36
1st Resistance Point 3.23
Last Price 3.11
1st Support Level 3.02
2nd Support Level 2.94
3rd Support Level 2.81

See More

52-Week High 7.55
Fibonacci 61.8% 5.83
Fibonacci 50% 5.31
Fibonacci 38.2% 4.78
Last Price 3.11
52-Week Low 3.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar